References
- Tuffanelli D., Abraham R. K., Dubois E. I. Pigmentation from antimalarial therapy. Arch Dermatol 1963; 88: 419–26
- Amichai B., Gat A., Grunwald M. H. Cutaneous hyperpigmentation during therapy with hydroxychloroquine. Clin Rheumatol 2007; 13: 113
- Dereure O. Drug‐induced skin pigmentation. Epidemiology, diagnosis and treatment. Am J Clin Dermatol 2001; 2: 253–62
- Butler D. F. Drug‐induced pigmentation., E‐medicine. URL: http://www.emedicine.com/derm/topic953.htm
- Chan L. S. Human skin basement membrane in health and in autoimmune diseases. Front Biosci 1997; 2: d343–52
- Shirahama S., Furukawa F., Yagi H., Tanaka T., Hashimoto T., Takigawa M. Bullous systemic lupus erythematosus: Detection of antibodies against noncollagenous domain of type VII collagen. J Am Acad Dermatol 1998; 38((5 Pt 2))844–8
- Alahlafi A. M., Wordsworth P., Wojnarowska F. The lupus band: Do the autoantibodies target collagen VII?. Br J Dermatol 2004; 150: 504–10
- Baniandrés O., Boixeda P., Belmar P., Pérez A. Treatment of lupus erythematosus with pulsed dye laser. Lasers Surg Med 2003; 32: 327–30
- Gupta G., Roberts D. T. Pulsed dye laser treatment of subacute cutaneous lupus erythematosus. Clin Exp Dermatol 1999; 24: 498–9
- Raulin C., Schmidt C., Hellwig S. Cutaneous lupus erythematosus – treatment with pulsed dye laser. Br J Dermatol 1999; 141: 1046–50